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Early versus delayed carotid endarterectomy in
symptomatic patients
Suman Annambhotla, MD, Michael S. Park, MD, Mark L. Keldahl, MD, Mark D. Morasch, MD,
Heron E. Rodriguez, MD, William H. Pearce, MD, Melina R. Kibbe, MD, and
Mark K. Eskandari, MD, Chicago, Ill
Background: Delayed carotid endarterectomy (CEA) after a stroke or transient ischemic attack (TIA) is associated with
risks of recurrent neurologic symptoms. In an effort to preserve cerebral function, urgent early CEA has been
recommended in many circumstances. We analyzed outcomes of different time intervals in early CEA in comparison with
delayed treatment.
Study Design: Retrospective chart review from a single university hospital tertiary care center between April 1999 and
November 2010 revealed 312 patients who underwent CEA following stroke or TIA. Of these 312 patients, 69 received
their CEA within 30 days of symptom onset and 243 received their CEA after 30 days from symptom onset. The early
CEA cohort was further stratified according to the timing of surgery: group A (27 patients), within 7 days; group B (17),
between 8 and 14 days; group C (12), between 15 and 21 days; and group D (12), between 22 and 30 days. Demographic
data as well as 30-day (mortality, stroke, TIA, and myocardial infarction) and long-term (all-cause mortality and stroke)
adverse outcome rates were analyzed for each group. These were also analyzed for the entire early CEA cohort and
compared against the delayed CEA group.
Results: Demographics and comorbid conditions were similar between groups. For 30-day outcomes, there were no
deaths, 1 stroke (1.4%), 0 TIAs, and 0 myocardial infarctions in the early CEA cohort; in the delayed CEA cohort, there
were 4 (1.6%), 4 (1.6%), 2 (0.8%), and 2 (0.8%) patients with these outcomes, respectively (P > .05 for all comparisons).
Over the long term, the early group had one ipsilateral stroke at 17 months and the delayed group had two ipsilateral
strokes at 3 and 12 months. For long-term outcomes, there were 16 deaths in the early CEA cohort (21%) and 74 deaths
in the delayed CEA cohort (30%, P > .05). Mean follow-up times were 4.5 years in the early CEA cohort and 5.8 years
in the delayed CEA cohort.
Conclusions:There were no differences in 30-day and long-term adverse outcome rates between the early and delayed CEA
cohorts. In symptomatic carotid stenosis patients without evidence of intracerebral hemorrhage, carotid occlusion, or
permanent neurologic deficits early carotid endarterectomy can be safely performed and is preferred over delaying
operative treatment. (J Vasc Surg 2012;56:1296-302.)
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IThe role of carotid endarterectomy (CEA) in the man-
agement of symptomatic carotid stenosis has been firmly
established based on several landmark prospective random-
ized trials from the 1990s.1-3 Early intervention within 2
weeks of symptom onset has been advocated and become
standard of care for most patients with transient ischemic
attacks (TIAs). However, for many years the approach in
the setting of acute stroke has been to defer operative
intervention for 4 to 6 weeks from the onset of symptoms
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1296ue to the prospect of recurrent intraoperative stroke and
schemic to hemorrhagic stroke conversion. This is thought
o occur as a result of compromise of the blood–brain
arrier and loss of cerebrovascular autoregulation. The
arly literature from the second half of the 20th century
eported several adverse outcomes related to early interven-
ion for symptomatic carotid stenosis.4-7However, many of
hese early reports were published before the era of com-
uted tomography (CT) and magnetic resonance imaging
MRI) and before the ability to aggressively control blood
ressure in an intensive care unit.8
While deferral of surgical intervention is intended to
educe the risks of periprocedural embolic or hemorrhagic
vents, there is an interval threat of ischemic recurrence.
he most frequently cited reports have suggested rates of
% to 2% of recurrent ischemic events within the first week
nd 2% to 4% in the first month.9-12 These rates, however,
ay be understated as other authors describe rates as high
s 9% to 10% within 7 days.13,14 Results from the North
merican Symptomatic Carotid Endarterectomy Trial
NASCET) and European Carotid Surgery Trial (ECST)
ubgroup analyses suggest greatest benefit with early inter-
ention and improved outcomes as shown by the National
nstitutes of Health Stroke Scale.15,16 Both trials demon-
trated greatest risk reduction for recurrent stroke if endar-
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Volume 56, Number 5 Annambhotla et al 1297terectomy was performed within 7 days of symptom onset.
Restoration of cerebral blood flow can salvage neuronal
tissue at risk in the penumbra, prevent recurrence of stroke,
and avert progression to occlusion.17
We report a single-center 10-year experience of CEA
performed for symptomatic carotid stenosis. We postulate
that there is no difference in 30-day and long-term primary
outcomes of stroke, myocardial infarction (MI), and death
with early vs delayed treatment. Furthermore, outcomes of
early CEA by time elapsed from symptom onset to treat-
ment are evaluated in a subgroup analysis.
METHODS
All CEA procedures performed for symptomatic ca-
rotid stenosis at Northwestern Memorial Hospital, Chi-
cago, Illinois, between April 21, 1999 and November 30,
2010, were retrospectively reviewed per approved institu-
tional review board protocols. Patients had one of the
following within 3 months of their procedure to classify as
a symptomatic neurologic event: hemispheric TIA or stroke
resulting in facial, upper, or lower extremity weakness, or
dysarthria, aphasia, or syncope as evidenced by a formal
neurology evaluation. Patients with amaurosis fugax or
ocular lesions were excluded. Patients were referred by
primary care practitioners, independent neurologists, or
emergency room physicians. All patients underwent preop-
erative bilateral carotid artery duplex examination and were
found to have stenosis 50% (NASCET criteria) on the
symptomatic side. Patients received either a CT or MRI of
the neck and brain to assess the carotid and cerebral circu-
lation and the presence, location, and size of any infarct.
Daily antiplatelet (aspirin 81 or 325 mg) therapy was
implemented preoperatively if not already active. Clopi-
dogrel was used in certain patients dependent on the refer-
ring physician and anatomic characteristics of the carotid
lesion.
Patients undergoing CEA within 30 days of symptom
onset were classified in the “early CEA” group. In this
cohort, patients were further categorized into one of four
groups by time from symptom onset to treatment: group A,
0 to 7 days; group B, 8 to 14 days; group C, 15 to 21 days;
group D, 22 to 30 days. Patients undergoing CEA after 30
days from symptom onset were classified into the “delayed
CEA” group. Symptomatic patients who might otherwise
have been offered CEA underwent carotid angioplasty and
stenting on the basis of anatomic criteria (surgically inac-
cessible lesion, neck irradiation, reoperative neck, or con-
tralateral laryngeal nerve paralysis) or if part of an organized
trial. These patients were excluded from the review. Also,
patients with carotid occlusion, hemorrhagic stroke, or
extensive permanent neurologic deficits were not offered
operative management.
Operative technique. All procedures were performed
under general anesthesia by experienced, board-certified
vascular surgeons using standard endarterectomy with
patch closure or eversion endarterectomy. Selective shunt-
ing based on carotid stump pressure measurement was
utilized at the discretion of the operating surgeon. Patients fere neurologically monitored in the postoperative anes-
hesia care unit and then transferred to the standard surgical
ard. High-risk patients or those exhibiting hypertension
r hypotension were observed in the intensive care unit.
Follow-up protocol. Neurologic examinations were
erformed by the operating surgeon and neurologist in the
mmediate and long-term postoperative period. Stroke was
efined as any new central neurologic deficit that persisted
eyond 24 hours regardless of evidence of an infarct on CT
r MRI. TIA was defined as any new central neurologic
eficit that resolved within 24 hours after initial onset. MI
as defined by at least two of the following criteria: typical
hest pain lasting 20 minutes or more; serum levels of
reatine kinase (CK), CK-MB, or troponin at least twice the
pper limit of the normal range; and newQwave on at least
wo adjacent derivations or predominant R waves in V1 (R
ave 1 mm  S wave in V1). Patients were clinically
e-evaluated at 1 and 12 months.
Outcomes. Thirty-day mortality, stroke, and MI rates
or groups A, B, C, and D, as well as for the “early CEA”
roup and the “delayed CEA” groups in total were ana-
yzed. Long-term outcomes of stroke rate and all-cause
ortality were also evaluated as far as 10 years from oper-
tive intervention. Data for patient characteristics by age,
ender, hypertension, smoking status, hyperlipidemia,
hronic renal disease, diabetes mellitus, history of MI,
ercutaneous coronary artery revascularization, clopidogrel
se, side of operation, middle cerebral artery (MCA) terri-
ory stroke, contralateral carotid occlusion, intraoperative
hunt use, and patch closure vs eversion technique were
lso collected for secondary analysis.
Statistical analysis. Baseline patient characteristics
nd postoperative outcomes between groups A, B, C, and
, as well as between early and delayed CEA groups, were
ompared using the 2 or Fisher exact test (for small n or
ighly imbalanced table cells). Data were summarized us-
ng descriptive statistics (ie, count and frequency for cate-
orical variables; age as the lone continuous variable in the
nalysis was summarized using mean and standard devia-
ion). Kaplan-Meier survival curves were fitted for the four
arly CEA groups as well the early and delayed CEA group
n total and patient survival was compared using log-rank
ests. Multivariate Cox proportional hazards models were
onstructed to identify independent risk factors of long-
erm postoperative mortality and stroke. The hazard ratio
stimates were based on simultaneous analysis of all predi-
ated variables. Assumption of proportionality was tested
sing log-minus-log plot and was met. Statistical signifi-
ance was determined at a two-sided P value of .05. All
tatistical analyses were conducted using SAS v. 9.2 (SAS
nc, Cary, NC).
ESULTS
There were 69 patients who underwent CEA within 30
ays of symptom onset and 243 after 30 days. Within the
arly CEA group, 27 patients received their CEAwithin the
rst week, 17 the second week, and 12 each in the third and
ourth weeks. One patient was not categorized in the
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November 20121298 Annambhotla et alsubgroup analysis as the patient underwent CEA within 30
days, but it was unclear exactly when the onset of symptoms
occurred. Demographic data are presented in Table I.
Comparison of the four early CEA groups did not reveal
any differences with regard to mean age, percentage of
octogenarians, males, patients with hypertension, diabetes,
history of tobacco use, hypercholesterolemia, dialysis, or
preoperative clopidogrel use. There was a higher propor-
tion of smoking and history of MI in the early CEA group
(27/69 vs 58/243, P  .012).
With regard to surgical indications, 80% of patients
underwent early CEA for stroke vs 62% in the delayed
group (55/69 vs 151/243, respectively). In terms of ana-
tomic considerations, there was very little difference by
subgroup or by early vs delayed CEA in terms of patch vs
eversion endarterectomy. There was a statistically signifi-
cant difference in the shunt use between groups (P .05).
Fifty-two percent (36/69) of patients had a shunt used in
the early endarterectomy group vs 28% (68/243) in the
Table I. Demographic characteristics
Early CEA (within
Group A Group B Group C
n 27 17 12
Mean age, years (SD) 68.6 (9.8) 68.8 (14.7) 67.5 (14.3)
Age 80 years 4 6 2
Male 16 9 8
Hypertension 24 14 10
Diabetes 7 3 3
Smoker 11 7 6
PTCA 2 0 1
Hyperlipidemia 16 12 9
h/o MI 7 3 2
Dialysis 0 1 0
Clopidogrel 8 5 2
Indication: stroke 20 14 9
Indication: TIA 7 3 3
Shunt 15 11 3
Patch 25 12 9
CEA, Carotid endarterectomy; MI, myocardial infarction; PTCA, percutan
ischemic attack.
aOne patient underwent early CEA, but exact symptom onset was unclear.
Table II. Thirty-day and long-term mortality, stroke, and
Early CEA (
Group A Group B Group
n 27 17 12
30-day outcomes
Mortality 0 0 0
Stroke 0 (6%) 1 0
MI 0 0 0
Long-term outcomes (10 years)
Mortality (26%) 7 (29%) 5 (16%)
Stroke (11%) 3 (6%) 1 (8%) 1
MI (7%) 2 0 0
CEA, Carotid endarterectomy; MI, myocardial infarction.
aOne patient underwent early CEA, but exact symptom onset was unclear.delayed group. It is unclear why this trend occurred. Per- haps this is due to increased collateral development in the
elayed group, therefore not requiring a shunt. There was
o correlation between stroke or death and eversion vs
atch or shunt use.
Rates of 30-day mortality, stroke, and MI, as well as
ong-term stroke and death rates are shown in Table II. Of
atients receiving early CEA, the only adverse outcome was
postoperative hemorrhagic stroke in a patient who under-
ent CEA 9 days after the onset of symptoms resulting in
ys)
Late CEA
(after 30 days)
P by
groups
P early vs
lateroup D Early CEA
12 69a 243
0.7 (9.3) 68.9 (11.7) 70.4 (9.7) .93 .27
2 14 (20%) 46 (19%) .42 .80
8 42 (61%) 159 (65%) .92 .48
12 61 (88%) 205 (84%) .51 .40
3 16 (23%) 61 (25%) .71 .74
3 27 (39%) 58 (24%) .68 .012
0 3 (4%) 28 (11%) .66 .07
9 47 (68%) 160 (66%) .42 .72
3 15 (22%) 26 (11%) .90 .016
0 1 (1%) 2 (1%) .60 .63
3 18 (26%) 52 (21%) .48 .79
11 55 (80%) 151 (62%) .66 .006
1 14 (20%) 92 (38%) .66 .006
6 36 (52%) 68 (28%) .20 .0002
10 57 (83%) 189 (78%) .23 .38
transluminal coronary angioplasty; SD, standard deviation; TIA, transient
rates
days)
Late CEA
(30 days) P by groups
P early vs
lateGroup D Early CEA
12 69a 243
0 0 (1.6%) 4 1.00 0.58
0 (1.4%) 1 (1.6%) 4 0.60 1.00
0 0 (0.8%) 2 1.00 1.00
(16%) 2 (23%) 16 (30%) 74 0.86 0.24
(16%) 2 (10%) 7 (7%) 16 0.82 0.30
0 (3%) 2 (5%) 12 0.79 0.74
able III. Anatomic characteristics
Early CEA Delayed CEA P value
CA territory stroke 32 (46%) 94 (39%) .29
eft side 40 (58%) 128 (53%) .43
ontralateral carotid
occlusion 10 (14%) 22 (9%) .14
EA, Carotid endarterectomy; MCA, middle cerebral artery.30 da
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Volume 56, Number 5 Annambhotla et al 1299of hyperperfusion syndrome and poor blood pressure man-
agement. No 30-day deaths or MIs were observed in this
cohort. The rates of 30-day death, stroke, and MI were
similarly low (4/243, 4/243, 2/243, respectively) in pa-
tients undergoing delayed CEA; there were no statistically
significant differences in any of these outcomes by sub-
group or by early vs delayed CEA.
Anatomic characteristics, including location and side of
the intracranial lesions comparing early and delayed groups
are shown in Table III. Also, contralateral carotid occlusion
is reported. There was no statistically significant difference
in the two groups; however, there was a larger percentage
of early endarterectomy patients with MCA territory
strokes and contralateral carotid occlusions. MCA territory
strokes were seen in nearly half of all symptomatic patients
(46% early, and 39% delayed groups).
Of the patients undergoing early CEA, all cause mor-
tality was seen in 16 patients during the 10-year follow-up
period; seven in group A, five in group B, and two each in
groups C and D. Seventy-four patients in the delayed CEA
group expired during long-term follow-up. There were
seven strokes, including contralateral or other embolic
sources during follow-up in the early CEA cohort. There
was no difference in the rate of either mortality or stroke by
group or by early vs delayed CEA.
Figs 1 and 2 showKaplan-Meier survival curves for each
Fig 1. Subgroupof the four subgroups and for the early and delayed CEA iroups, respectively. Log-rank analyses revealed no differ-
nce in survival in either comparison. Mean survival of
atients in the early CEA group was 6.6 years and 7.9 years
or patients in the delayed CEA group.
ISCUSSION
The timing of carotid endarterectomy after recent neu-
ologic event has been debated for several decades and is
till controversial. Many factors come into play when assess-
ng timing of symptom onset. Patient delay to endarterec-
omy may be a result of delay in presentation, delay in
eferral, or at the discretion of the operating surgeon. The
nitial literature4-7 presented clinical data supporting delay
f surgical intervention for more than 6 weeks due to
oncern for ischemic to hemorrhagic conversion. Giordano
t al18 reported an 18.5% perioperative stroke rate in 27
atients undergoing CEA within 5 weeks of acute stroke
ompared with 0% in the delayed CEA group. Rockman et
l19 reviewed their 10-year CEA experience and reported a
ignificantly higher rate (5.1%) of perioperative stroke in
heir early CEA group (n 604) than in their delayed CEA
roup (1.6%, n  442, P  .01). The evidence was
ignificant, but most was reported in the era before
mproved imaging modalities (CT, MRI) could better
haracterize infarcts and close pre- and postoperative
lood pressure management could be carried out in an
lan-Meier curve.ntensive care setting.
d
p
r
u
R
c
d
a
N
G
c
o
i
s
p
T
a
m
i
t
p
e
yed K
JOURNAL OF VASCULAR SURGERY
November 20121300 Annambhotla et alThe vast majority of contemporary literature supports
early intervention. The foundation of early endarterectomy
in symptomatic patients began with the improved results of
pooled analysis from the ECST and NASCET trials in the
1990s.1-3 Rantner, et al demonstrated no difference in
major complication rates in 29 CEAs performed before or
62 CEAs performed after 28 days from symptoms.20 More
importantly, they observed secondary ischemic stroke in
11.8% of their delayed CEA cohort during the 4-week
waiting period. Ballotta et al21 showed in a prospective
study of 45 patients randomized to early CEA and 41
randomized to delayed CEA that there was no difference in
perioperative stroke rates, survival, or stroke-free survival at
3 years. Capoccia et al17 reported that 93.5% (58/62) of
patients undergoingCEAwithin 2 weeks of symptom onset
experienced National Institutes of Health Stroke Scale
score improvement upon treatment. Finally, as in this
study, Paty et al22 reported no difference in the rates of
perioperative stroke resulting in permanent neurologic def-
icit by time elapsed after symptom onset (week 1: 2/72,
2.8%; week 2: 2/59, 3.4%; week 3: 1/29, 3.4%; week 4:
2/78, 2.6%).
Retrospective analysis from this study indicates that the
majority of the delay to operative treatment was a result of
Fig 2. Early vs delapatient presentation and referral patterns. Many patients sid not recognize the severity of initial symptom onset and
resented upon recurrence, delaying care. Furthermore,
eferral for endarterectomy in many instances did not occur
ntil complete workup and identification of carotid disease.
eferring physicians became more aggressive about early
onsultation for surgery towards the latter part of the
ecade. Practice patterns within the vascular surgery group
lso shifted towards earlier endarterectomy.
Anatomic considerations showed interesting findings.
early half of all patients exhibited MCA territory strokes.
reater than 10% of the entire cohort had contralateral
arotid occlusion. Patients with occlusion or80% stenosis
f the contralateral carotid had a shunt utilized. At our
nstitution, selective shunting is implemented by checking
tump pressures. Approximately 50% of the symptomatic
atients had a shunt used, but this included patients with
IAs or old infarcts that had resolution of symptoms. We
dvocate mandatory shunting of all patients with a docu-
ented clinical or radiological acute ipsilateral cerebral
nfarction. In further analyzing the data, there was a trend
oward greater shunt usage for acute strokes in the latter
art of the decade. There was an increase in shunt use in the
arly endarterectomy group suggesting increased symptom
aplan-Meier curve.everity and greater carotid disease, but this is unclear.
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evolution in the guidelines regarding carotid endarterec-
tomy after acute stroke and TIA. Previous recommenda-
tions23 entailed delay of carotid endarterectomy after acute
stroke for 4 to 6 weeks. The most recent 2011 Society of
Vascular Surgery guidelines have taken the aggregate data
of the NASCET and ECST trials as well as recent reports
into account and encourage CEA to be performed within 2
weeks of the neurologic event.24,25 The European Society
for Vascular Surgery guidelines also recommend CEA
within 2 weeks of symptom onset.26
There are some limitations to this study. It was rela-
tively small, especially for the subgroup comparison within
the early CEA groups. Also, the data was retrospectively
analyzed from a single institution and patients were not
randomized. The patient groups, despite the results in
Table I, may not be directly comparable, particularly as
selection criteria for early CEA may be different from the
criteria for delayed CEA. The size of the preoperative
infarct on imaging was not described within the confines of
this review. Nonetheless, the results from this study appear
to be consistent with most of the recent retrospective
analyses regarding the timing of carotid endarterectomy
after acute stroke.
CONCLUSIONS
Consistent with recent evidence, our single-institution
experience does not show any statistically significant differ-
ence in rates of 30-day or long-term mortality or stroke
between early and delayed carotid endarterectomy. Addi-
tionally, we have demonstrated no difference in adverse
event rates by time elapsed from symptom onset to surgical
intervention. There was a small, though not statistically
significant, increase in perioperative stroke and death rate in
the delayed endarterectomy group, perhaps attributable to
a statistical error. Early endarterectomy may prevent recur-
rent embolic events and interval strokes without increased
perioperative stroke and death risk. Carotid endarterec-
tomy may be performed with success as early as two weeks
in neurologically symptomatic patients. Appropriate stroke
severity and risk stratification should be taken into account
when performing early CEA.
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Dr R. Clement Darling, III (Albany NY). I want to thank the
SouthernVascular Society for the honor of allowingme to discuss this
excellent paper. This is truly a wonderful society and I amhumbled by
being a member. Early carotid endarterectomy after recent stroke has
been associated with increased risks of recurrent neurologic symp-
toms. Unfortunately, delaying carotid endarterectomy has also been
associated with even more increase in potential neurologic complica-
tions for the patient. Thus, the 6-week waiting period was designed
more to protect the surgeon than it was to protect the patient. Dr
Philip Paty from our group wrote a nice paper demonstrating our
results, which are duly noted in Dr Annambhotla’s manuscript. It is
always reassuring to have one’s data corroborated by a more modern
study. I thought that the authors did an excellent job in collating their
data. I have a few questions for the author.
(1) Do the authors have any data on the size of infarct by CT or
MR in regard to outcome? Is there a size that the authors
would decide not to do an early carotid endarterectomy due to
extended infarct or was the decision to intervene solely on
clinical findings?
(2) If you eliminated the patients with transient ischemic attacks,
was there any difference in stroke rates due to time of carotid
endarterectomy after primary event? Were there any patients
excluded in the trial due to their severity of stroke comorbid-
ity, patient or physician refusal?
(3) Lastly, do the neurologists in your institution accept this data and
refer patients for early intervention for patientswith hemodynam-
ically significant carotid bifurcation disease and stroke?
Again, I want to thank the society for allowing me to review
this paper. I would like to congratulate the authors on a superbDr Suman Annambhotla. Thank you, Dr Darling, for your
ind words. In answering your first question, we have not looked at
pecific CT scan infarct size, but are in the process of compiling and
ooking at that data. The ultimate goal is to correlate the infarct
ize on CT or MRI with timing of the endarterectomy and clinical
utcomes. As far as basing the intervention on infarct size, looking
ack at the numbers that are currently being reviewed, we did not
nd any specific infarct size where the decision was to not perform
n endarterectomy. Specifically, there was no absolute number, but
cm to 4 cm infarct size has been proposed in the literature and
emains to be addressed.
In regards to your second question about stroke vs TIA, we
ad four postoperative strokes in the delayed group, three of which
nitially presented with a stroke and only one with a TIA. In the
arly endarterectomy group, only one patient had a postoperative
troke and they had presented with a stroke. In total, there were
ve postoperative strokes, and only one initially presented with a
IA.
Regarding the third question, at Northwestern, the relation-
hip between the neurology service and vascular service is one of
irect communication in managing acute carotid-related stroke
atients. This has evolved over the last 10 years with the neurolo-
ists being more aggressive in pushing for early endarterectomy.
nterestingly, the neurology literature advocated early endarterec-
omy in TIA and stroke in evolution patients, and the vascular
iterature has followed suit only in the last decade. We work in
oordination with the neurologists at both Northwestern and the
A in treating these patients in an early fashion within 48 hours to
week.
